Ling‐I Hsu

854 total citations
30 papers, 572 citations indexed

About

Ling‐I Hsu is a scholar working on Oncology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ling‐I Hsu has authored 30 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ling‐I Hsu's work include Arsenic contamination and mitigation (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Heavy Metal Exposure and Toxicity (4 papers). Ling‐I Hsu is often cited by papers focused on Arsenic contamination and mitigation (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Heavy Metal Exposure and Toxicity (4 papers). Ling‐I Hsu collaborates with scholars based in United States, Taiwan and Switzerland. Ling‐I Hsu's co-authors include Chien‐Jen Chen, Hung‐Yi Chiou, Yu‐Mei Hsueh, Chi‐Ling Chen, Meei‐Maan Wu, Ling‐Ling Hsieh, Yi‐Hsiang Hsu, Minli Wei, Huiting Yang and Fang‐I Hsieh and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ling‐I Hsu

26 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ling‐I Hsu United States	12	255	222	155	80	66	30	572
Johnny Shinn Nan Lin Taiwan	11	241 0.9×	209 0.9×	252 1.6×	57 0.7×	81 1.2×	15	688
Ling-I Hsu Taiwan	15	347 1.4×	323 1.5×	194 1.3×	29 0.4×	26 0.4×	19	597
Poojitha Balakrishnan United States	12	187 0.7×	195 0.9×	151 1.0×	35 0.4×	22 0.3×	22	604
Kvetoslava Koppová Hungary	15	392 1.5×	479 2.2×	183 1.2×	53 0.7×	88 1.3×	25	898
Nathalie Saint‐Jacques Canada	13	171 0.7×	160 0.7×	104 0.7×	56 0.7×	273 4.1×	28	799
Minli Wei China	6	340 1.3×	260 1.2×	231 1.5×	31 0.4×	41 0.6×	10	623
Chien Jen Chen Taiwan	6	380 1.5×	320 1.4×	232 1.5×	35 0.4×	164 2.5×	10	1.0k
Catherine L. Callahan United States	14	138 0.5×	232 1.0×	78 0.5×	34 0.4×	62 0.9×	27	528
C J Chen Taiwan	5	257 1.0×	230 1.0×	115 0.7×	21 0.3×	21 0.3×	7	493
Hugo Benítez Chile	5	210 0.8×	206 0.9×	72 0.5×	21 0.3×	65 1.0×	7	375

Countries citing papers authored by Ling‐I Hsu

Since Specialization

Citations

This map shows the geographic impact of Ling‐I Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐I Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐I Hsu more than expected).

Fields of papers citing papers by Ling‐I Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling‐I Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐I Hsu. The network helps show where Ling‐I Hsu may publish in the future.

Co-authorship network of co-authors of Ling‐I Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Ling‐I Hsu. A scholar is included among the top collaborators of Ling‐I Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling‐I Hsu. Ling‐I Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsu, Ling‐I, et al.. (2025). Geographic and Hospital Variations in the Use of Red Blood Cells and Tranexamic Acid among Total hip and Total Knee Arthroplasty. SHILAP Revista de lepidopterología. 16(1). 27–33.

Schwartz, Naomi, et al.. (2023). Burden of illness in metastatic colorectal cancer.. Journal of Clinical Oncology. 41(4_suppl). 53–53.

Bekaii‐Saab, Tanios, Ling‐I Hsu, Muriel Siadak, et al.. (2023). Impact of Anti-EGFR Therapies on HER2-Positive Metastatic Colorectal Cancer: A Systematic Literature Review and Meta-Analysis of Clinical Outcomes. The Oncologist. 28(10). 885–893. 16 indexed citations

Singh, Harshabad, Lisa Bloudek, Ling‐I Hsu, et al.. (2023). Systematic literature review and meta-analysis of HER2 amplification, overexpression, and positivity in colorectal cancer. JNCI Cancer Spectrum. 8(1). 9 indexed citations

Kaufman, Peter A., Naomi Schwartz, Shu Wang, et al.. (2023). Real-world patient characteristics, treatment patterns, and clinical outcomes associated with tucatinib therapy in HER2-positive metastatic breast cancer. Frontiers in Oncology. 13. 7 indexed citations

Strickler, John H., Ling‐I Hsu, Phoebe Wright, et al.. (2023). Real-World Treatment Patterns in Patients With HER2-Amplified Metastatic Colorectal Cancer: A Clinical-Genomic Database Study. Journal of the National Comprehensive Cancer Network. 21(8). 805–812.e1. 5 indexed citations

Anders, Carey K., Naomi Schwartz, Karen Bartley, et al.. (2023). Real-world patient characteristics and treatment patterns associated with tucatinib therapy in patients with HER2+ metastatic breast cancer.. Journal of Clinical Oncology. 41(16_suppl). 1051–1051. 2 indexed citations

Wu, Meei‐Maan, Chi‐Wei Chen, Chih‐Hung Lee, et al.. (2022). TIMP3 Gene Polymorphisms of -1296 T > C and -915 A > G Increase the Susceptibility to Arsenic-Induced Skin Cancer: A Cohort Study and In Silico Analysis of Mutation Impacts. International Journal of Molecular Sciences. 23(23). 14980–14980.

Hsu, Ling‐I, et al.. (2021). An imbalance in blood collection and demand is anticipated to occur in the near future in Taiwan. Journal of the Formosan Medical Association. 121(8). 1610–1614. 8 indexed citations

10.

Guérin, Annie, Raluca Ionescu‐Ittu, Sherry Shi, et al.. (2018). Comparative Effectiveness of Non-cisplatin First-line Therapies for Metastatic Urothelial Carcinoma: Phase 2 IMvigor210 Study Versus US Patients Treated in the Veterans Health Administration. European Urology Oncology. 2(1). 12–20. 15 indexed citations

11.

Hsu, Ling‐I, Farren Briggs, Xiaorong Shao, et al.. (2016). Pathway Analysis of Genome-wide Association Study in Childhood Leukemia among Hispanics. Cancer Epidemiology Biomarkers & Prevention. 25(5). 815–822. 12 indexed citations

12.

Hsu, Ling‐I, Anand P. Chokkalingam, Farren Briggs, et al.. (2015). Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children. Cancer Causes & Control. 26(4). 609–619. 19 indexed citations

13.

Guérin, Annie, Saurabh Ray, Geneviève Gauthier, et al.. (2015). The Healthcare Resource Utilization, Costs, and Predictors of Progression Among Relapsed and Refractory CLL Patients. Blood. 126(23). 3313–3313. 1 indexed citations

14.

Chokkalingam, Anand P., Ling‐I Hsu, Catherine Metayer, et al.. (2013). Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics. Cancer Causes & Control. 24(10). 1789–1795. 40 indexed citations

15.

Chen, Chien‐Jen, Wan-Fen Li, Ling‐I Hsu, et al.. (2012). Elevated lactate dehydrogenase activity and increased cardiovascular mortality in the arsenic-endemic areas of southwestern Taiwan. Toxicology and Applied Pharmacology. 262(3). 232–237. 27 indexed citations

16.

Murk, William, Kyle M. Walsh, Ling‐I Hsu, et al.. (2011). Attempted Replication of 50 Reported Asthma Risk Genes Identifies a SNP in RAD50 as Associated with Childhood Atopic Asthma. Human Heredity. 71(2). 97–105. 38 indexed citations

17.

Chen, Chi‐Ling, Hung‐Yi Chiou, Ling‐I Hsu, et al.. (2009). Ingested arsenic, characteristics of well water consumption and risk of different histological types of lung cancer in northeastern Taiwan. Environmental Research. 110(5). 455–462. 95 indexed citations

18.

Liao, Chung‐Min, Chi‐Ling Chen, Ling‐I Hsu, et al.. (2008). Risk assessment of arsenic-induced internal cancer at long-term low dose exposure. Journal of Hazardous Materials. 165(1-3). 652–663. 43 indexed citations

19.

Liao, Chung‐Min, Tzu-Ling Lin, Szu‐Chieh Chen, et al.. (2007). Arsenic cancer risk posed to human health from tilapia consumption in Taiwan. Ecotoxicology and Environmental Safety. 70(1). 27–37. 18 indexed citations

20.

Chiou, Hung‐Yi, Yu‐Mei Hsueh, Ling‐Ling Hsieh, et al.. (1997). Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutation Research/Reviews in Mutation Research. 386(3). 197–207. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact